Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

Nilotinib is an FDA approved drug used for the treatment of Philadelphia Chromosome Positive CML, which is a cancer of blood ...

Cipla has received final US FDA approval for its Nilotinib Capsules (50 mg, 150 mg, 200 mg) for the treatment of Philadelphia ...

Cipla announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the new drug application (NDA) submitted for 'Nilotinib Capsules 50, 150 and 200 mg' ...

Mumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs ...

HYDERABAD, India (Reuters) - Indian pharmaceutical companies will be able to retain their dominant market share in the U.S.

The freeze has put orders and forecasts, particularly those made months in advance, on hold. Read more at straitstimes.com.

Mumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) submitted for ‘Nilotinib Capsules 50, ...

The Nifty futures ended on a positive note, gaining 0.21% to close at 23,043 levels on Monday. Meanwhile, the India VIX ...

The U.S. foreign aid freeze has severely impacted the supply chain for medical products in poor countries, causing potential shortages in HIV and malaria treatments. This disruption affects major ...

Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...